TuHURA Biosciences, Inc.
HURA· Nasdaq
HURATuHURA Biosciences, Inc.
Filed Sep 13, 2016 · 10-K · 75 days after period end · 0001213900-16-016715
derived · Computed from the longer spans the company filed.
| Metric | Q4 2016dderived from reported figures | Q4 2015dderived from reported figures | Q4 2014dderived from reported figures | Q4 2012 |
|---|---|---|---|---|
| Revenue | — | — | — | $0.00 |
| Net Income | $14.27M | -$2.65M | $1.90M | -$3.25K |
| EPS Diluted | — | — | — |
TuHURA Biosciences, Inc. · CIK 1498382 · Engraved from SEC EDGAR
| $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ended Jun 30, 2016 · filed Sep 13, 2016 · 75 d after period end
